New clinical trial to examine safety of checkpoint inhibitor in pediatric cancer patientshealthmedicinetAugust 18, 2016news / o comments Children’s Hospital Los Angeles Related posts: HMN 2025: How Proof-of-concept innate immune checkpoint inhibitor shows promise against solid tumors in rodents HMN 2025: How Checkpoint inhibitor promotes tissue repair, offering hope for chronic wound treatment Previous Post New collaborative study aims to identify mutations to improve clinical management of breast cancer Next Post Scientists find way to boost efficiency with which CRISPR-Cas9 cuts and disables genes
